Additional factors that could improve cost-effectiveness of pharmacogenetic-guided dosing in warfarin therapy

Benjamin P. Geisler, Jeffrey K. Levin-Scherz

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{84d09053c4af4e36a0e0ae28edbc16fc,

title = "Additional factors that could improve cost-effectiveness of pharmacogenetic-guided dosing in warfarin therapy",

author = "Geisler, {Benjamin P.} and Levin-Scherz, {Jeffrey K.}",

year = "2009",

month = jul,

day = "7",

doi = "10.7326/0003-4819-151-1-200907070-00016",

language = "English",

volume = "151",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "AMERICAN COLLEGE OF PHYSICIANS",

number = "1",

}

TY - JOUR

T1 - Additional factors that could improve cost-effectiveness of pharmacogenetic-guided dosing in warfarin therapy

AU - Geisler, Benjamin P.

AU - Levin-Scherz, Jeffrey K.

PY - 2009/7/7

Y1 - 2009/7/7

UR - http://www.scopus.com/inward/record.url?scp=67650082876&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-151-1-200907070-00016

DO - 10.7326/0003-4819-151-1-200907070-00016

M3 - Letter

C2 - 19581651

AN - SCOPUS:67650082876

SN - 0003-4819

VL - 151

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 1

ER -